The U.S. military is utilizing the services of Anomaly 6, a private surveillance firm, to assist in the investigation of Havana syndrome, an illness reported by various American intelligence officers. Documents obtained through a Freedom of Information Act request indicate that Anomaly 6's technology is being employed by the Pentagon's Anomalous Health Incidents Cross Functional Team, which examines unusual health symptoms among personnel from U.S. spy agencies and the State Department.
Anomaly 6, based in Virginia, has previously demonstrated its surveillance capabilities by tracking the movements of CIA and NSA employees using bulk cellular location data. The Pentagon has a history of employing commercial device tracking technology, and the contract with Anomaly 6 is valued at nearly $6 million, set to last until September.
The Air Force has not disclosed the specific reasons for selecting Anomaly 6 for this investigation. The contract, referred to as Project Yellowfin, outlines that the company will provide expertise in location intelligence to identify relevant actors and activities. The contract also specifies the creation of data visualization products to assist decision-makers.
The investigation may be linked to the belief among some Havana syndrome patients that their symptoms result from covert attacks by foreign governments. However, a report from the U.S. intelligence community indicated that most agencies believe it is unlikely that these symptoms are caused by a national adversary. The Air Force did not respond to inquiries regarding the use of Anomaly 6's location data in relation to this investigation.